Prepandemic avian influenza vaccines authorized for human use in the United States and European Union

Name	Form	Manufacturer	Authorization
Pandemic influenza H5N1 vaccine	Monovalent subunit (nonadjuvanted)	Sanofi	United States (2007)
Adjupanrix	Monovalent recombinant H5N1 subunit vaccine adjuvanted with AS03	GSK	United States (2013) European Union (2009)
Aflunov	Monovalent subunit H5N1 vaccine adjuvanted with MF59	Novartis	European Union (2010)
Foclivia	Monovalent subunit H5N1 vaccine adjuvanted with MF59	Seqirus	European Union (2011)
Audenz	Monovalent subunit H5N1 vaccine adjuvanted with MF59	Seqirus	United States (2020)
Pandemic influenza vaccine H5N1 Baxter AG	Whole-virion vaccine	Baxter (previously Celvapan)	European Union (2009)
Pandemic influenza vaccine H5N1 AstraZeneca	Live attenuated, nasal vaccine	AstraZeneca	European Union (2016)

Graphic 141146 Version 3.0